Journal
JCI INSIGHT
Volume 1, Issue 10, Pages -Publisher
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/jci.insight.86419
Keywords
-
Categories
Funding
- NHLBI NIH HHS [P01 HL018646] Funding Source: Medline
- NIAID NIH HHS [U19 AI102405, P01 AI123086, U01 AI094374] Funding Source: Medline
Ask authors/readers for more resources
Successful induction of allograft tolerance has been achieved in nonhuman primates (NHPs) and humans via induction of transient hematopoietic chimerism. Since allograft tolerance was achieved in these recipients without durable chimerism, peripheral mechanisms are postulated to play a major role. Here, we report our studies of T cell immunity in NHP recipients that achieved long-term tolerance versus those that rejected the allograft (AR). All kidney, heart, and lung transplant recipients underwent simultaneous or delayed donor bone marrow transplantation (DBMT) following conditioning with a nonmyeloablative regimen. After DBMT, mixed lymphocyte culture with CFSE consistently revealed donor-specific loss of CD8(+) T cell responses in tolerant (TOL) recipients, while marked CD4(+) T cell proliferation in response to donor antigens was found to persist. Interestingly, a significant proportion of the proliferated CD4(+) cells were FOXP3(+) in TOL recipients, but not in AR or naive NHPs. In TOL recipients, CD4(+) FOXP3(+) cell proliferation against donor antigens was greater than that observed against third-party antigens. Finally, the expanded Tregs appeared to be induced Tregs (iTregs) that were converted from non-Tregs. These data provide support for the hypothesis that specific induction of iTregs by donor antigens is key to long-term allograft tolerance induced by transient mixed chimerism.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available